(NASDAQ: SSKN) Strata Skin Sciences's forecast annual revenue growth rate of 3.35% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.78%.
Strata Skin Sciences's revenue in 2025 is $30,980,000.On average, 4 Wall Street analysts forecast SSKN's revenue for 2025 to be $179,548,852, with the lowest SSKN revenue forecast at $168,543,808, and the highest SSKN revenue forecast at $189,075,958. On average, 4 Wall Street analysts forecast SSKN's revenue for 2026 to be $193,450,890, with the lowest SSKN revenue forecast at $182,593,051, and the highest SSKN revenue forecast at $202,648,257.
In 2027, SSKN is forecast to generate $211,521,773 in revenue, with the lowest revenue forecast at $200,852,356 and the highest revenue forecast at $220,295,189.